We are live on ! Find out more
NA

Navellier & Associates Portfolio holdings

AUM $1.26B
1-Year Est. Return 95.39%
This Fund
S&P 500
This Quarter Est. Return
+18.37%
1 Year Est. Return
+95.39%
3 Year Est. Return
+360.87%
5 Year Est. Return
+519.82%
10 Year Est. Return
+3,025.56%
AUM
$552M
AUM Growth
+$93.9M
Cap. Flow
+$34M
Cap. Flow %
6.16%
Top 10 Hldgs %
20.37%
Holding
306
New
79
Increased
86
Reduced
92
Closed
31

Sector Composition

Rank Sector Weight
1 Technology 35.55%
2 Healthcare 14.68%
3 Consumer Discretionary 10.4%
4 Industrials 9.71%
5 Consumer Staples 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAD icon
226
Lithia Motors
LAD
$8.26B
$297K 0.05%
1,016
-82
-7% -$22.4K
TAL icon
227
TAL Education Group
TAL
$6.91B
$294K 0.05%
4,110
-157
-4% -$11.3K
CVGW
228
DELISTED
Calavo Growers
CVGW
$292K 0.05%
4,208
+66
+2% +$4.66K
MHH icon
229
Mastech Digital
MHH
$95.7M
$284K 0.05%
17,838
-936
-5% -$16.9K
MLAB icon
230
Mesa Laboratories
MLAB
$565M
$282K 0.05%
985
-104
-10% -$28.6K
HIMX
231
Himax Technologies
HIMX
$2.4B
$280K 0.05%
+37,917
New +$194K
FMC icon
232
FMC
FMC
$1.32B
$277K 0.05%
+2,411
New +$268K
APPF icon
233
AppFolio
APPF
$6.87B
$276K 0.05%
1,534
-40
-3% -$6.4K
VIG icon
234
Vanguard Dividend Appreciation ETF
VIG
$114B
$272K 0.05%
1,924
+14
+0.7% +$1.9K
SSTK icon
235
Shutterstock
SSTK
$217M
$265K 0.05%
+3,692
New +$245K
ELA icon
236
Envela
ELA
$468M
$264K 0.05%
+50,749
New +$226K
SRNE
237
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$262K 0.05%
+38,453
New +$309K
PG icon
238
Procter & Gamble
PG
$342B
$259K 0.05%
1,863
IBDP
239
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$258K 0.05%
9,715
NVEE
240
DELISTED
NV5 Global
NVEE
$255K 0.05%
+12,960
New +$218K
VRSN icon
241
VeriSign
VRSN
$26.4B
$254K 0.05%
+1,173
New +$240K
STMP
242
DELISTED
Stamps.com, Inc.
STMP
$250K 0.05%
+1,272
New +$279K
AME icon
243
Ametek
AME
$57.6B
$248K 0.04%
+2,049
New +$231K
TRIB
244
Trinity Biotech
TRIB
$7.86M
$248K 0.04%
+433
New +$215K
INFU icon
245
InfuSystem Holdings
INFU
$236M
$247K 0.04%
+13,177
New +$199K
JPM icon
246
JPMorgan Chase
JPM
$947B
$247K 0.04%
+1,940
New +$217K
NVTA
247
DELISTED
Invitae Corporation
NVTA
$246K 0.04%
+5,885
New +$281K
DGX icon
248
Quest Diagnostics
DGX
$26.3B
$242K 0.04%
+2,031
New +$248K
EVTC icon
249
Evertec
EVTC
$1.85B
$236K 0.04%
6,005
-685
-10% -$25.4K
BFAM icon
250
Bright Horizons
BFAM
$3.89B
$230K 0.04%
+1,332
New +$218K

Similar funds

Navellier & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Navellier & Associates held 306 positions worth $552M, up 20% from $458M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Navellier & Associates deployed $34M of net new capital in Q4 2020, opening 79 new positions and adding to 86 existing holdings. Its largest new stake was Ball Corp: 76,750 shares worth $7.15M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was EPAM Systems, an estimated $2.63M trimmed.

  • Navellier & Associates's largest Q4 2020 buy was Ball Corp: 76,750 shares worth $7.15M.
  • Navellier & Associates added most to Idexx Laboratories in Q4 2020, an estimated $7.37M increase.
  • Navellier & Associates's biggest Q4 2020 reduction was EPAM Systems, cutting an estimated $2.63M.
  • Navellier & Associates fully exited Mastercard in Q4 2020, selling an estimated $7.01M.
  • Navellier & Associates's ten largest holdings make up 20% of its $552M portfolio in Q4 2020.
  • Navellier & Associates opened 79 new positions and closed 31 in Q4 2020.
  • Navellier & Associates's portfolio value rose 20% quarter-over-quarter to $552M.

Based on Navellier & Associates's 13F filing for Q4 2020, filed 5 Feb 2021.